المؤلفون: Mathie Najberg, Muhammad Haji Mansor, Frank Boury, Carmen Alvarez-Lorenzo, Emmanuel Garcion

المصدر: Frontiers in Pharmacology, Vol 10 (2019)

مصطلحات موضوعية: tumor cell migration, tumor trap, biomimetic trap, cancer therapy, premetastatic niche recruitment, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fphar.2019.00887/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/4a93b27de455411cac5f55523c909d13

المؤلفون: Frank Boury, Muhammad Haji Mansor, Mathie Najberg, Baya Gueza, Emmanuel Garcion, Carmen Alvarez-Lorenzo, Christine Jérôme, Rodolfo Molina-Peña, Jean-Michel Thomassin

المساهمون: Bernardo, Elizabeth, Design and Application of Innovative Local Treatments in Glioblastoma (CRCINA-ÉQUIPE 17), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Center for Education and Research on Macromolecules - CERM [Liège, Belgium], Université de Liège-CESAM RU [Liège, Belgium], SFR UA 4208 Interactions Cellulaires et Applications Thérapeutiques (ICAT), Université d'Angers (UA), Universidade de Santiago de Compostela [Spain] (USC ), Instituto de Investigación Sanitaria de Santiago de Compostela / Health Research Institute of Santiago de Compostela (IDIS), EuroNanoMed III (project GLIOSILK 'Silk-fibroin interventional nano-trap for the treatment of glioblastoma'), LabEx IRON 'Innovative Radiopharmaceuticals in Oncology and Neurology' as part of the French government 'Investissements d’Avenir' program, INCa (Institut National du Cancer) MARENGO consortium 'MicroRNA agonist and antagonist Nanomedicines for Glioblastoma treatment: from molecular programmation to preclinical validation' [Grant PL-BIO 2014-2020], French Région Pays-de-la-Loire (Bioimplants for Bone Regeneration (BILBO) part of the BIOREGATE Research-Training-Innovation consortium (RFI) and NanoFar +), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Angers, France, Agencia Estatal de Investigación (AEI) and Instituto de Salud Carlos III (ISCIII) [AC19/00067] Cofinanciado FEDER, Spain, FEDER (FMF - Prostem) for the University of Liege (Liege, Belgium), Ministère de l'Enseignement supérieur, de la Recherche et de l’Innovation (MESRI), France, European Project: AN33.32R

المصدر: International Journal of Pharmaceutics
International Journal of Pharmaceutics, 2021, 610, pp.121205. ⟨10.1016/j.ijpharm.2021.121205⟩

مصطلحات موضوعية: Stromal cell, [SDV.BIO]Life Sciences [q-bio]/Biotechnology, Glioblastoma cell trap, Stromal cell-derived factor-1α (SDF-1α), [SDV]Life Sciences [q-bio], Nanofibers, Pharmaceutical Science, [SDV.CAN]Life Sciences [q-bio]/Cancer, Metastasis, chemistry.chemical_compound, Mice, [SDV.CAN] Life Sciences [q-bio]/Cancer, In vivo, medicine, Animals, Chitosan nanofibrous scaffold, [SDV.IB.BIO]Life Sciences [q-bio]/Bioengineering/Biomaterials, Tissue Scaffolds, Electrospinning, Chemistry, Adhesion, medicine.disease, In vitro, Chemokine CXCL12, Cell biology, Rats, PLGA, [CHIM.POLY]Chemical Sciences/Polymers, Delayed-Action Preparations, Cancer cell, NIH 3T3 Cells, Nanoparticles, Pseudopodia, Poly(lactic-co-glycolic acid) (PLGA) nanoparticles, Sustained release

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0719c89aaef68d02744324e7903f8cd4
https://www.hal.inserm.fr/inserm-03546708

المؤلفون: Emmanuel Garcion, José Luis Cenis, Mathie Najberg, Céline Bouré, Frank Boury, Rodolfo Molina-Peña, Carmen Alvarez-Lorenzo, Muhammad Haji Mansor, Théodore Taillé

المساهمون: Design and Application of Innovative Local Treatments in Glioblastoma (CRCINA-ÉQUIPE 17), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Instituto Murciano de Investigación y desarrollo Agrario y Alimentario (IMIDA), Universidade de Santiago de Compostela [Spain] (USC ), Bernardo, Elizabeth, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)

المصدر: Carbohydrate Polymers
Carbohydrate Polymers, Elsevier, 2020, 237, pp.116107. ⟨10.1016/j.carbpol.2020.116107⟩
Carbohydrate Polymers, 2020, 237, pp.116107. ⟨10.1016/j.carbpol.2020.116107⟩

مصطلحات موضوعية: Polymers and Plastics, Scanning electron microscope, Lysine, Fibroin, Silk fibroin, Biocompatible Materials, [SDV.CAN]Life Sciences [q-bio]/Cancer, 02 engineering and technology, 010402 general chemistry, 01 natural sciences, Miscibility, Mice, chemistry.chemical_compound, [SDV.CAN] Life Sciences [q-bio]/Cancer, Porous scaffold, Hyaluronic acid, Materials Chemistry, medicine, Animals, Hyaluronic Acid, Aerogel sponges, Tissue Engineering, Tissue Scaffolds, Heparin, Chemistry, Organic Chemistry, Aerogel, Biodegradation, 021001 nanoscience & nanotechnology, Chemokine CXCL12, 0104 chemical sciences, 3. Good health, Brain biomimicry, NIH 3T3 Cells, Swelling, medicine.symptom, Fibroins, 0210 nano-technology, Gels, Porosity, SDF-1α controlled release, Nuclear chemistry

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f559aabe0ae7b7a6a4c5be7bc0a9ee2
https://www.hal.inserm.fr/inserm-02912531

المؤلفون: Mathie Najberg, Muhammad Haji Mansor, Aurelien Contini, Emmanuel Garcion, Carmen Alvarez-Lorenzo, Frank Boury, Christine Jérôme

المساهمون: Bernardo, Elizabeth, Design and Application of Innovative Local Treatments in Glioblastoma (CRCINA-ÉQUIPE 17), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Departamento de Farmacologia, Farmacia y Tecnología Farmacéutica [La Coruña, Spain], Universidade de Santiago de Compostela [Spain] (USC ), Centre d'Etude et de Recherche sur les Macromolécules (CERM), Université de Liège, Authors would like to thank the French Ministry of Higher Education and Research for their financial support (PhD Grant) and the National Funds for Scientific Research, Belgium (FNRS) for additional financial assistance. The authors are thankful for the European financial support (EACEA) in the frame of the NanoFar program, an Erasmus Mundus Joint Doctorate (EMJD) program in nanomedicine and pharmaceutical innovation. This work was also supported by 'La Région Pays-dela-Loire', by the 'Institut National de la Santé et de la Recherche Médicale' (INSERM), by the 'University of Angers' and the 'University of Liège' and by the 'Cancéropôle Grand-Ouest' though the 'glioblastoma' and 'vectorization and radiotherapies' networks., Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)

المصدر: European Journal of Pharmaceutics and Biopharmaceutics
European Journal of Pharmaceutics and Biopharmaceutics, 2018, Epub ahead of print. ⟨10.1016/j.ejpb.2017.12.020⟩
European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2018, Epub ahead of print. ⟨10.1016/j.ejpb.2017.12.020⟩

مصطلحات موضوعية: 0301 basic medicine, Protein encapsulation, Stromal cell-derived factor-1α (SDF-1α), Drug Compounding, Stabiliser, Pharmaceutical Science, Nanoparticle, [SDV.CAN]Life Sciences [q-bio]/Cancer, 02 engineering and technology, Polyethylene glycol, Polyethylene Glycols, Polymeric nanoparticles, 03 medical and health sciences, chemistry.chemical_compound, Mice, [SDV.CAN] Life Sciences [q-bio]/Cancer, PEG ratio, Animals, Polyglactin 910, ComputingMilieux_MISCELLANEOUS, Drug Carriers, Dose-Response Relationship, Drug, technology, industry, and agriculture, General Medicine, 021001 nanoscience & nanotechnology, Chemokine CXCL12, PLGA, Drug Liberation, 030104 developmental biology, chemistry, Chemical engineering, Delayed-Action Preparations, NIH 3T3 Cells, Nanomedicine, Nanoparticles, Muramidase, Nanocarriers, Lysozyme, 0210 nano-technology, Biotechnology, Sustained release

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61c722270504a6bb3c5aa5ab78b90fc
https://doi.org/10.1016/j.ejpb.2017.12.020

المؤلفون: Sami Hietala, Polina Ilina, Arto Urtti, Mathie Najberg, Tina Borke, Heikki Tenhu, Madhushree Bhattacharya

المساهمون: Department of Chemistry, Laboratory of Polymer Chemistry (-2016), Faculty of Pharmacy, Bioactivity Screening Group, Division of Pharmaceutical Biosciences, Drug Delivery, Drug Research Program, Polymers, Drug Delivery Unit

المصدر: Macromolecular Bioscience. 18:1700200

مصطلحات موضوعية: Glycerol, Polymers and Plastics, Biocompatibility, Polymers, 116 Chemical sciences, drug delivery vehicle, Glyceryl Ethers, Bioengineering, 02 engineering and technology, 010402 general chemistry, 01 natural sciences, vitreous, Biomaterials, polymer-from-polymer release, chemistry.chemical_compound, Retinal Diseases, hyaluronic acid, Polymer chemistry, Hyaluronic acid, Materials Chemistry, Side chain, Copolymer, Humans, Drug Carriers, Water, 021001 nanoscience & nanotechnology, Combinatorial chemistry, 0104 chemical sciences, Molecular Weight, Vitreous Body, Kinetics, chemistry, Intravitreal Injections, Drug delivery, poly(glyceryl glycerol), 0210 nano-technology, Drug carrier, Biotechnology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e30a88d4917374c78484b7fb8cdcb2
https://doi.org/10.1002/mabi.201700200